scholarly journals Burning mouth syndrome (BMS) – clinical symptoms

ORL ro ◽  
2021 ◽  
Vol 3 (1) ◽  
pp. 34-36 ◽  
Author(s):  
Elena Claudia Coculescu ◽  
Bogdan-Ioan Coculescu
Keyword(s):  
Medical Practice ◽  
Clinical Symptoms ◽  
Burning Mouth Syndrome ◽  
Dental Disease ◽  
Know How ◽  
Secondary Form ◽  
Burning Mouth ◽  
Attending Physician

The scientific news and the importance for medical practice of approaching this oro-dental disease is supported not only by the patient’s persistent long-term suffering, but also by the concern to know how to identify the possible etiopathogenesis, especially in the secondary form, which once identified and sanctioned therapeutically is successful for both the attending physician and the patient.  

Evaluation of serum neuron specific enolase levels among patients with primary and secondary burning mouth syndrome

Cephalalgia ◽  
2021 ◽  
pp. 033310242110466
Author(s):  
Jaimala Kishore ◽  
Fouzia Shaikh ◽  
Adnan Mustafa Zubairi ◽  
Sana Mirza ◽  
Montaser N Alqutub ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Spinal Cord Injuries ◽  
Clinical Symptoms ◽  
Neuron Specific Enolase ◽  
Burning Mouth Syndrome ◽  
Enzyme Linked Immunosorbent Assay ◽  
Painful Condition ◽  
Burning Mouth ◽  
A Minor ◽  
Serum Neuron Specific Enolase

Introduction Burning mouth syndrome is a painful condition of the oral cavity with ambiguous pathogenesis and diagnosis. Neuron-specific enolase is increased in several conditions including peripheral neuropathy of diabetes, ophthalmopathies, spinal cord injuries and tumors. Evidence on association of burning mouth syndrome and neuron-specific enolase is limited. Aim This study aims to evaluate neuron-specific enolase levels in primary and secondary burning mouth syndrome patients and compare the levels of neuron-specific enolase with associated conditions in secondary burning mouth syndrome. Methods One hundred and twenty-eight patients of more than 18 years of age with no gender predilection and having clinical symptoms of burning mouth syndrome and 135 healthy subjects were included. All the patients fulfilled Scala’s criteria for the diagnosis of burning mouth syndrome, including “primary” (idiopathic) and “secondary” (resulting from identified precipitating factors) burning mouth syndrome patients. Blood samples were obtained from burning mouth syndrome patients. Serum neuron-specific enolase was evaluated using enzyme-linked immunosorbent assay. To compare means and standard deviations, among primary and secondary burning mouth syndrome, data was analysed with analysis of variance and multiple comparisons test. Results The mean age of the study participants for burning mouth syndrome and healthy subjects was 53.30 and 51.6 years, respectively. Amongst the secondary burning mouth syndrome group, 32 (25%) of the patients had menopause, 15 (11.7%) had diabetes, eight (6.2%) of the patients had nutritional deficiency, seven (5.4%) had combined diabetes, menopause, and depression, six (4.6%) had combined diabetes and depression, four (3.1%) were diagnosed with Sjögren’s syndrome. A minor percentage of 2.3% (three) had gastroesophageal reflux disease, while the remaining three (2.3%) patients in the secondary burning mouth syndrome group were on anti-depressants. There was a statistically significant increase in the levels of neuron-specific enolase in primary burning mouth syndrome as compared to the secondary burning mouth syndrome and healthy groups. Among the subgroups of secondary burning mouth syndrome, diabetic individuals showed a significant increase in neuron-specific enolase level when compared with other conditions in the secondary burning mouth syndrome patients. Discussion and conclusion: The raised serum neuron-specific enolase levels in patients suffering from primary burning mouth syndrome highlight a possible neuropathic mechanism. It was also increased in the sub-group of secondary burning mouth syndrome patients having diabetes. Although it cannot be ascertained whether the deranged values in the diabetic group were due to burning mouth syndrome or due to diabetes, the raised quantity of neuron-specific enolase in the primary burning mouth syndrome group is a reliable diagnostic indicator. Future studies on the assessment of neuron-specific enolase levels as a diagnostic tool for onset and management of primary and secondary burning mouth syndrome are recommended.

scholarly journals Mandibular Nerve Block for Long-Term Pain Relief in a Case of Refractory Burning Mouth Syndrome

2020 ◽  
Vol 9 (1) ◽  
pp. 345-347
Author(s):  
Hisham Kassem ◽  
Lucien Alexandre ◽  
Ivan Urits ◽  
Alan D. Kaye ◽  
Omar Viswanath
Keyword(s):  
Pain Relief ◽  
Nerve Block ◽  
Burning Mouth Syndrome ◽  
Mandibular Nerve ◽  
Burning Mouth

scholarly journals Pitfalls for diagnosis of burning mouth-like syndrome

2021 ◽  
Vol 67 (3) ◽  
pp. 150-155
Author(s):  
Raluca Ema Pîrvu ◽  
◽  
Ioanina Părlătescu ◽  
Șerban Țovaru ◽  
Cosmin Dugan ◽  
...  
Keyword(s):  
Oral Cavity ◽  
Medical Practice ◽  
Burning Mouth Syndrome ◽  
Diagnostic Approach ◽  
Anxiety And Depression ◽  
Endocrine Disorders ◽  
Systemic Diseases ◽  
Burning Mouth ◽  
Scientific Framework

This research gives a scientific framework for burning mouth syndrome(BMS) etiology and diagnostic approach in clinical dental and medical practice. BMS-like symptoms can be induced by systemic diseases such as diabetes, gastrointestinal, endocrine disorders, allergy etc. or by local oral cavity conditions as candidiasis or geographic tongue or odontogenic causes. Because the etiology of BMS is multifactorial, treatment can only be distinctive, and is aimed at relieving symptoms. The complexity of BMS symptoms and associated psychosocial infirmities, anxiety and depression raise the need for a multidisciplinary and individualised approach.

scholarly journals Support Group as a Management Modality for Burning Mouth Syndrome: A Randomized Prospective Study

2021 ◽  
Vol 11 (16) ◽  
pp. 7207
Author(s):  
Talia Becker ◽  
Yafit Hamzani ◽  
Gavriel Chaushu ◽  
Shlomit Perry ◽  
Bahaa Haj Yahya
Keyword(s):  
Support Group ◽  
Clinical Symptoms ◽  
Medical Center ◽  
Life Quality ◽  
Burning Mouth Syndrome ◽  
Rank Test ◽  
Control Group ◽  
Before And After ◽  
Burning Mouth ◽  
Group Sessions

We aimed to investigate the effectiveness of a support group in the management of burning mouth syndrome (BMS). The cohort included 22 adult patients with BMS who attended the oral and maxillofacial department of a tertiary medical center in 2014–2019 and agreed to participate in the study. Eleven patients were assigned to a support group and took part in 90 min sessions held once weekly for 4 weeks (a total of 4 sessions), and the remainder continued their previous individual BMS management routine (control group). All patients completed a life-quality questionnaire before and 3 months after the group sessions. Scores for each group were compared between the two time points with a Wilcoxon signed-rank test. There was a significant decrease in scores for malaise (p = 0.041), total pain (p = 0.046), and difficulty enjoying food (p = 0.026) before and after the group sessions in the study group. No significant changes were found in the control group in any of the parameters examined. A group support can alleviate pain and other clinical symptoms of BMS. Further longer-term prospective studies are needed to corroborate our findings.

scholarly journals A systematic review of treatment for patients with burning mouth syndrome

Cephalalgia ◽  
2021 ◽  
pp. 033310242110361
Author(s):  
Huann Lan Tan ◽  
Jared G Smith ◽  
Jan Hoffmann ◽  
Tara Renton
Keyword(s):  
Pain Score ◽  
Lipoic Acid ◽  
Cognitive Behaviour Therapy ◽  
Burning Mouth Syndrome ◽  
Alpha Lipoic Acid ◽  
Behaviour Therapy ◽  
Cognitive Behaviour ◽  
Burning Mouth

Background Burning mouth syndrome is a chronic idiopathic intractable intraoral dysaesthesia that remains a challenge to clinicians due to its poorly understood pathogenesis and inconsistent response to various treatments. Aim This review aimed to study the short- (≤3 months) and long-term (>3 months) effectiveness and sustainable benefit of different burning mouth syndrome treatment strategies and the associated side effects. Materials and methods Randomised controlled trials of burning mouth syndrome treatment compared with placebo or other interventions with a minimum follow up of 2 months were searched from the PubMed, Embase and Cochrane database (published to July 2020). Results Twenty-two studies were selected based on the inclusion and exclusion criteria and analysed. Nine categories of burning mouth syndrome treatment were identified: Anticonvulsant and antidepressant agents, phytomedicine and alpha lipoic acid supplements, low-level laser therapy, saliva substitute, transcranial magnetic stimulation, and cognitive behaviour therapy. Cognitive behaviour therapy, topical capsaicin and clonazepam, and laser therapy demonstrated favourable outcome in both short- and long-term assessment. Phytomedicines reported a short-term benefit in pain score reduction. The pooled effect of alpha lipoic acid (ALA) pain score improvement was low, but its positive effects increased in long term assessment. Conclusion A more significant volume in terms of sample size, multi-centres, and multi-arm comparison of therapeutic agents with placebo and longitudinal follow-up studies is recommended to establish a standardised burning mouth syndrome treatment protocol. Further studies are required to assess the analgesic benefits of topical clonazepam and capsaicin, alternative medicines with neurodegenerative prevention capability and psychology support in treating burning mouth syndrome and reducing systemic adverse drug reactions. Registration International Prospective Register of Systematic Reviews (PROSPERO): Protocol ID - CRD42020160892.

scholarly journals Suicidal Behavior in a Patient with Burning Mouth Syndrome

2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Konstantinos Kontoangelos ◽  
Evmorfia Koukia ◽  
Vasilis Papanikolaou ◽  
Aris Chrysovergis ◽  
Antonis Maillis ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Oral Cavity ◽  
Psychiatric Comorbidity ◽  
Burning Mouth Syndrome ◽  
Burning Sensation ◽  
Multiple Forms ◽  
Case Presentation ◽  
Local Pain ◽  
Burning Mouth

Introduction. Chronic pain of the oral cavity is a long-term condition and like all other types of chronic pain is associated with numerous comorbidities such as depression or anxiety.Case Presentation. This is a case of a 93-year-old patient suffering from chronic oral cavity pain who repeatedly stabbed his palate due to ongoing local pain, over the last few months, which he could not further tolerate. The patient was suffering from depression and also a diagnosis of “burning mouth syndrome” (BMS) was made.Discussion. Burning mouth syndrome (BMS) is characterized by a burning sensation in the tongue or other oral sites. BMS has high psychiatric comorbidity but can occur in the absence of psychiatric diagnosis. Patients with multiple forms of pain must be considered as potential candidates for underdiagnosed depression (major) and suicidal thoughts.

scholarly journals Personality Traits in Burning Mouth Syndrome Patients With and Without a History of Depression

2021 ◽  
Vol 12 ◽  
Author(s):  
Trang Thi Huyen Tu ◽  
Motoko Watanabe ◽  
Takayuki Suga ◽  
Chaoli Hong ◽  
Chihiro Takao ◽  
...  
Keyword(s):  
Clinical Symptoms ◽  
Burning Mouth Syndrome ◽  
Mcgill Pain Questionnaire ◽  
Psychiatric History ◽  
History Of ◽  
Personality Facets ◽  
Burning Mouth ◽  
Pain Symptoms ◽  
Depression History ◽  
History Of Depression

Objectives: So far, the strong link between neuroticism, chronic pain, and depression has been well-documented in literatures. Some suggested that they might share etiological factors, thus resulting in overlapping constructs. However, such effect has never been tested in burning mouth syndrome (BMS) patients, a complex phenomenon influenced by both neuropathic and psychopathological factors. We aim to clarify how personality affects individual's pain and pain-related experiences.Methods: Two hundred forty-eight patients with BMS provided demographic information and psychiatric history; completed Ten-Item Personality Inventory, a Visual Analog Scale of pain, and McGill Pain Questionnaire; and provided adequate parameters of depressive state, catastrophizing thinking, and central sensitization.Results: BMS patients with depression history suffered more severe clinical symptoms and scored higher in neuroticism and less in openness and extraversion than did those without psychiatric diagnoses. After age, sex, and duration of pain were controlled, neuroticism in BMS patients with depression correlates with affective dimension of pain. Instead, if psychiatric history is absent, neuroticism correlates with sensory dimension and pain intensity. In both groups, higher neuroticism, unlike other personality facets, contributed to a more severe clinical condition.Conclusion: Of the five traits, neuroticism appears to be the most crucial dimension associated with the pain symptoms and patient's conditions. This study implies that management of pain must extend beyond solely providing pain-relieving medication and must require a holistic and multidisciplinary approach.

Burning Mouth Syndrome

2013 ◽  
Vol 56 (9) ◽  
pp. 550
Author(s):  
Jae Won Chang ◽  
Chul-Ho Kim
Keyword(s):  
Burning Mouth Syndrome ◽  
Burning Mouth

Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome

Oral Diseases ◽  
2012 ◽  
Vol 18 (6) ◽  
pp. 613-620 ◽  
Author(s):  
H-Il Kim ◽  
Y-Y Kim ◽  
J-Y Chang ◽  
J-Y Ko ◽  
H-S Kho
Keyword(s):  
Salivary Cortisol ◽  
Burning Mouth Syndrome ◽  
17Β Estradiol ◽  
Burning Mouth
Sign in / Sign up

Export Citation Format

Share Document